In the BioHarmony Drug Report Database

"Preview" Icon

Brilliant blue g

Tissueblue (brilliant blue g) is a small molecule pharmaceutical. Brilliant blue g was first approved as Tissueblue on 2019-12-20. It is known to target P2X purinoceptor 7.

 

Trade Name

 

Tissueblue
 

Common Name

 

brilliant blue g
 

ChEMBL ID

 

CHEMBL4173394
 

Indication

 

 

Drug Class

 

Image (chem structure or protein)

Brilliant blue g structure rendering